Bionik Laboratories

OverviewSuggest Edit

Bionik Laboratories is a medical device and robotics company developing transformational robotic rehabilitation technologies for individuals with neurological disorders. The Company is dedicated to providing individuals with restricted mobility an improvement in overall health, comfort, accessibility, and quality of life through the commercialization of its proprietary products. The Company’s lead program, ARKE is the most comprehensive lower-body exoskeleton that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking. Currently, in clinical development, ARKE will initially be used in a rehabilitation environment, with the goal of being made available for home use.
TypePublic
Founded2009
HQToronto, CA
Websitebioniklabs.com

Latest Updates

Employees (est.) (Jun 2019)28(+4%)
Revenue (FY, 2018)$987.4 K(+73%)
Share Price (Jan 2020)$1

Key People/Management at Bionik Laboratories

Eric Dusseux

Eric Dusseux

Co-Founder and Chief Technology Officer
Renaud Maloberti

Renaud Maloberti

Chief Commercial Officer
Malcolm G. Bock

Malcolm G. Bock

Vice President of Engineering
Show more

Bionik Laboratories Office Locations

Bionik Laboratories has offices in Toronto and Watertown
Toronto, CA (HQ)
483 Bay St
Watertown, US
80 Coolidge Hill Rd
Show all (2)

Bionik Laboratories Financials and Metrics

Bionik Laboratories Revenue

Bionik Laboratories's revenue was reported to be $987.43 k in FY, 2018
USD

Net income (FY, 2019)

(10.6m)

Market capitalization (8-Jan-2020)

5.1m

Closing stock price (8-Jan-2020)

1.0

Cash (31-Mar-2019)

446.8k
Bionik Laboratories's current market capitalization is $5.1 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

7.5k5.2k6.0k571.9k987.4k

Cost of goods sold

7.0k388.8k402.7k1.6m

Gross profit

(1.0k)183.2k584.8k

Gross profit Margin, %

(17%)32%59%
Quarterly
USDQ3, 2011Q1, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

3.5k15.0k1.2k1.0k1.5k1.5k1.5k1.5k164.2k18.3k372.4k87.5k221.8k261.0k

Cost of goods sold

58.9k12.0k334.8k29.3k59.8k88.4k253.2k384.1k450.3k

Gross profit

105.3k6.3k37.6k58.2k162.0k172.6k

Gross profit Margin, %

64%34%10%67%73%66%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

12.5k4.9k4.4k3.2k6.6m5.4m543.7k507.3k446.8k

Accounts Receivable

125.2k212.7k1.5m

Prepaid Expenses

188.2k231.7k433.7k1.4m

Inventories

228.2k237.4k405.7k
Quarterly
USDQ3, 2011Q1, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

8.0k10.6k15.6k567.01.5k3.0k5.9k7.3k8.8k6.1m9.1m7.9m2.7m1.7m581.0k846.4k136.1k998.7k959.7k305.8k375.1k

Accounts Receivable

79.0120.4k93.9k253.8k134.9k37.2k306.6k370.2k517.8k1.5m

Prepaid Expenses

158.4k164.4k128.0k188.4k157.1k153.0k172.1k169.3k145.0k485.4k851.2k1.8m

Inventories

260.3k294.0k194.6k255.5k231.4k302.4k155.8k192.6k335.6k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(4.7k)(9.4k)(13.1k)(29.5k)(5.6m)(1.0m)(3.9m)(14.6m)10.6m

Depreciation and Amortization

59.5k14.4k629.9k412.9k348.2k

Inventories

(39.4k)(9.2k)(168.2k)

Accounts Payable

(1.5k)16.3k(174.2k)186.2k(332.0k)(60.1k)424.2k
Quarterly
USDQ3, 2011Q1, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

1.3k(1.9k)2.8k(2.9k)(8.7k)(10.5k)(917.0)(4.5k)(5.9k)(7.6m)(9.1m)(4.8m)(2.3m)(1.6m)(2.4m)(2.2m)(5.9m)(8.4m)(760.7k)4.7m7.1m

Depreciation and Amortization

10.4k27.4k42.9k10.2k33.8k57.8k24.6k48.4k69.6k17.6k34.2k50.2k

Inventories

(71.4k)(191.5k)(120.9k)(27.3k)(3.2k)(74.2k)81.6k44.8k(98.2k)

Accounts Payable

2.3k3.4k(71.8k)(111.9k)(178.2k)(703.5k)(696.9k)(718.3k)104.6k172.6k10.1k11.5k181.8k669.8k
USDY, 2019

Financial Leverage

1.1 x
Show all financial metrics

Bionik Laboratories Online and Social Media Presence

Embed Graph

Bionik Laboratories News and Updates

Medical Exoskeletons Market Comprehensive Study Explores Huge Growth in Future | Cyberdyne, Ekso Bionics, Rewalk Robotics, Bionik Laboratories, Rex Bionics

Stay up-to-date with Medical Exoskeletons market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

Robotic Rehabilitation and Assistive Technologies Market is Anticipated to grow at a CAGR by 2025- Accuray Incorporated, AlterG, Inc., Bionik Laboratories Corp., DIH Technologies Corporation

Rehabilitation robotics is a field of research dedicated to understanding and augmenting rehabilitation through the application of robotic devices. Posted via Industry Today. Follow us on Twitter @IndustryToday

Bionik Laboratories Files Registration Statement for Proposed Follow-On Offering

TORONTO and BOSTON, Oct. 30, 2018 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQB: BNKL) ("Bionik" or the "Company"), a pioneering healthcare company combining artificial intelligence and innovative robotics technology to help individuals from hospital to home to regain mobility,...

Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors

TORONTO and BOSTON, Sept. 13, 2018 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQB: BNKL) ("Bionik" or the "Company"), a pioneering healthcare company combining artificial intelligence and innovative robotics technology to help individuals from hospital to home to regain mobility,...

Bionik Laboratories Blogs

BIONIK Laboratories Selects Propel to Accelerate New Product Development and Manufacturing of InMotion Robotic Systems and Services

Propel to deploy its configurable cloud-based product success platform to enable BIONIK to accelerate time to market, ensure compliance, and increase productivity TORONTO & BOSTON & SANTA CLARA, California--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK"), a robotics…

BIONIK Laboratories Announces Second Quarter Fiscal 2020 Financial Results

TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced f…

BIONIK Laboratories Partners with Intelliware Development to Provide Seamless Connectivity Between InMotion™ Robotic Devices and Hospital Information Systems

Companies collaborate to produce customized dynamic data management platform to empower superior patient outcomes and increased asset productivity TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehab…

BIONIK Laboratories Appoints Loren Wass as Chief Commercial Officer

Industry veteran brings extensive experience driving the commercialization of robotic technologies within healthcare TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive …

BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, yesterday announce…

BIONIK Laboratories’ Fiscal 2019 Financial Results Feature 229% Increase in Sales

TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, yesterday announc…
Show more

Bionik Laboratories Frequently Asked Questions

  • When was Bionik Laboratories founded?

    Bionik Laboratories was founded in 2009.

  • Who are Bionik Laboratories key executives?

    Bionik Laboratories's key executives are Eric Dusseux, Renaud Maloberti and Malcolm G. Bock.

  • How many employees does Bionik Laboratories have?

    Bionik Laboratories has 28 employees.

  • Who are Bionik Laboratories competitors?

    Competitors of Bionik Laboratories include Neocis, OmniGuide and Restoration Robotics.

  • Where is Bionik Laboratories headquarters?

    Bionik Laboratories headquarters is located at 483 Bay St, Toronto.

  • Where are Bionik Laboratories offices?

    Bionik Laboratories has offices in Toronto and Watertown.

  • How many offices does Bionik Laboratories have?

    Bionik Laboratories has 2 offices.